
Pro Dex Inc
PDEXNasdaqCIK 788920HealthcareFiscal year ends Jun 30
Reports and events: 341 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-12-1516:06 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001079973-23-001772 |
| 2023-11-0216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-23-001523 |
| 2023-11-0216:00 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001079973-23-001522 |
| 2023-10-3016:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001079973-23-001498 |
| 2023-10-2716:01 ET | DEF 14A | Proxy statementPeriod 2023-12-14 | 0001079973-23-001489 |
| 2023-10-1717:00 ET | SC 13D | Ownership report, active investor | 0001079973-23-001453 |
| 2023-10-1316:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-23-001431 |
| 2023-10-1316:15 ET | 10-K | Annual reportPeriod 2023-06-30 | 0001079973-23-001429 |
| 2023-09-2816:00 ET | 8-K | 4.02 Non-reliance on financial statements | 0001079973-23-001329 |
| 2023-08-0716:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001079973-23-001065 |
| 2023-05-0416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001553350-23-000286 |
| 2023-05-0416:00 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001553350-23-000285 |
| 2023-02-0216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001553350-23-000063 |
| 2023-02-0216:00 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0001553350-23-000062 |
| 2023-01-0516:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001553350-23-000011 |
| 2022-11-1816:00 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001553350-22-000929 |
| 2022-11-0316:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001553350-22-000853 |
| 2022-11-0316:49 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001553350-22-000851 |
| 2022-10-0316:02 ET | DEF 14A | Proxy statementPeriod 2022-11-17 | 0001079973-22-001256 |
| 2022-09-0816:00 ET | 10-K | Annual reportPeriod 2022-06-30 | 0001553350-22-000745 |
| 2022-08-2516:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001553350-22-000721 |
| 2022-08-0816:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001553350-22-000648 |
| 2022-05-0516:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001553350-22-000398 |
| 2022-05-0516:01 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001553350-22-000397 |
| 2022-02-0316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001553350-22-000088 |
| 2022-02-0316:01 ET | 10-Q | Quarterly reportPeriod 2021-12-31 | 0001553350-22-000085 |
| 2021-12-2716:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001553350-21-001187 |
| 2021-12-2116:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001553350-21-001181 |
| 2021-11-1916:00 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001553350-21-001075 |
| 2021-11-1516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001553350-21-001031 |
| 2021-11-1516:01 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001553350-21-001029 |
| 2021-11-0916:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001553350-21-000973 |
| 2021-10-0516:00 ET | DEF 14A | Proxy statementPeriod 2021-11-18 | 0001553350-21-000882 |
| 2021-09-0916:01 ET | 10-K | Annual reportPeriod 2021-06-30 | 0001553350-21-000795 |
| 2021-09-0316:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001553350-21-000776 |
| 2021-08-2716:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001553350-21-000756 |
| 2021-08-2616:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001553350-21-000747 |
| 2021-05-2816:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001553350-21-000483 |
| 2021-05-0616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001553350-21-000336 |
| 2021-05-0616:00 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001553350-21-000335 |
| 2021-02-2516:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001553350-21-000153 |
| 2021-02-2216:47 ET | SC 13D/A | Ownership report, active investor, amended | 0000897069-21-000113 |
| 2021-02-0416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001553350-21-000097 |
| 2021-02-0416:00 ET | 10-Q | Quarterly reportPeriod 2020-12-31 | 0001553350-21-000096 |
| 2020-12-3116:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001553350-20-001134 |
| 2020-12-1116:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001553350-20-001095 |
| 2020-11-2516:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-20-129513 |
| 2020-11-2016:00 ET | 8-K | 5.07 Shareholder vote results | 0001553350-20-001045 |
| 2020-11-1213:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001553350-20-000989 |
| 2020-11-0516:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001553350-20-000969 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.